Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CRSP
CRISPR Therapeutics AG
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$55.32
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$5.35B
Country
USA
RECENT INSIDER TRADES
2026-10-08
· KASINGER JAMES R.
(General Counsel and Secretary)
· SELL
2026-10-08
· KASINGER JAMES R.
(General Counsel and Secretary)
· OTHER
2026-09-24
· KASINGER JAMES R.
(General Counsel and Secretary)
· SELL
2026-09-24
· KASINGER JAMES R.
(General Counsel and Secretary)
· OTHER
2026-09-21
· Behbahani Ali
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
559
Shares held
82,483,903
Value
$4.30B
Percent of shares outstanding
85.31%
As of quarter end
2026-06-30
RECENT NEWS
Cathie Wood’s ARK sells DraftKings stock and buys CRISPR Therapeutics
CRISPR Therapeutics to present CTX310 data at AHA Scientific Sessions
CRISPR Therapeutics to present Phase 1 data on zugo-cel at ACR Convergence 2026
Citizens reaffirms CRISPR Therapeutics price target at $80
CRISPR Therapeutics stock analysis: pipeline catalysts vs. financial reality
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
CRISPR Therapeutics AG (CRSP) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit